Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
MILWAUKEE, RICHMOND, Calif., ST LOUIS, PALO ALTO, Calif., and PARIS, July 23 /PRNewswire-FirstCall/ -- Scientists from The Medical College of Wisconsin in Milwaukee, Sangamo Biosciences, Inc., (Nasdaq: SGMO ), Sigma-Aldrich Corporation (Nasdaq: SIAL ), Open Monoclonal Technology...
Clinical and Histopathological Results Using Pollogen's TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
TEL AVIV, Israel, June 17 /PRNewswire/ -- A recent clinical study using
Pollogen's regen(TM) device- the latest aesthetic solution powered by 3rd
generation TriPollar(TM) technology, confirms the safety and efficacy of
TriPollar(TM) technology in reducing fat and collagen remodeling. The peer
UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
PITTSBURGH, Pennsylvania, and JERUSALEM, Israel, June 15 /PRNewswire/ --
The University of Pittsburgh Cancer Institute (UPCI) and the Gamida Cell -
Teva Joint Venture announced today that the Institute has joined an elite
group of cancer centers in Europe, the United States and Israel that a...
Definitive Outcomes of Radiofrequency Ablation for Barrett's Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons
Radiofrequency ablation is durable after 2 years, compares favorably with endoscopic resection for advanced disease, and reduces the risk for cancer progression
SUNNYVALE, Calif., June 3 /PRNewswire/ -- Results from a number of clinical trials were presented during the Digestive Disease Wee...
Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
The results of these studies will be presented during the American Transplant Congress in Boston , MA May 30 - June 3, 2009
COLUMBIA, Md., May 31 /PRNewswire/ -- The results of two large studies presented by researchers from the Starzl Transplant Institute at the University of P...
Spirus Medical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM)
CHICAGO, May 29 /PRNewswire/ -- Spirus Medical, Inc. ( www.spirusmed.com ), a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, urology and gynecology, announced that physicians using
its Endo-Ease(TM) line of devices have performed complete examinations o...
Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R)
Jason Hanft of Baptist Health South Florida Reports on 11 Patients at SAWC
PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Derma Sciences (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced that yesterday at the annual Symposium on the Advances in W...
PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
- Company Reports Significant Uptake of PlasmaBlade by U.S. Surgeons Since Product Launch -
PALO ALTO, Calif., April 7 /PRNewswire/ -- PEAK Surgical, Inc., a medical device company that has developed a new tissue dissection system based on a proprietary technology, announced today several mil...
Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms
ROCKVILLE, Md., March 16 /PRNewswire-USNewswire/ -- Patients and clinicians should consider risk factors -- including age, gender, diabetes, blood pressure, cholesterol levels, smoking and risk of gastrointestinal bleeding -- before deciding whether to use aspirin to prevent heart attacks or strok...
ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform
PARIS, March 16 /PRNewswire-FirstCall/ -- ExonHit Therapeutics
(Alternext: ALEHT) today reported the publication in Lancet Oncology of a
study conducted by Institut Gustave Roussy, which describes the
identification of a deregulated cell function in breast cancer through the
analysis of altern...
New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds
SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- Scleroderma is an autoimmune disease that leads to thickening and severe scarring of skin as well as thickening and failure of internal organs, including the lungs, heart, kidneys and intestines. The disease -- which the Scleroderma Foundation esti...
Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmer's Trabecular Metal(TM) Technology
10-Year Study Highlights Trabecular Metal Technology's Clinical Success Over Traditional Metal Implants
WARSAW, Ind., Feb. 25 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH ; SWX: ZMH), a leader in the orthopaedic industry, today announced that data from an independent 10-ye...
Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
Primate trials validate efficacy of the process
THOUSAND OAKS, Calif., Feb. 24 /PRNewswire/ -- Bone Biologics, Inc. announced today that it has successfully completed the initial primate trials validating the efficacy of the proprietary bone growth regeneration UCB-1 (NELL-1) protein in spina...
Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinson's Disease
LOS ANGELES, Feb. 16 /PRNewswire/ -- Scientists announced today the
publication of a landmark peer-reviewed paper in the February issue of the
Bentham Open Stem Cell Journal which outlines the long term results of the
world's first clinical trial using
autologous neural stem cells for the
Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
New study questions ability of human-animal hybrids to generate stem cells
WORCESTER, Mass., Feb. 2 /PRNewswire-FirstCall/ -- Advanced Cell Technology, Inc. (OTC Pink Sheets: ACTC) and its collaborators reported today that human oocytes (or 'eggs') have the capacity to extensively reprogram...
Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach
ROCKVILLE, Md. and NEW YORK, Jan. 27 /PRNewswire-USNewswire/ -- Researchers from the J. Craig Venter Institute (JCVI) and the Ludwig Institute for Cancer Research (LICR) have uncovered new genomic alterations that lead to gene fusions in a breast cancer cell line by using
454 Life Sciences sequenc...
NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
Sanarus' Visica 2(TM) Treatment System Selected as Exclusive Cryoablation Treatment Technology
PLEASANTON, Calif., Oct. 28 /PRNewswire/ -- The American College of
Surgeons Oncology Group (ACOSOG) which just initiated a National Cancer
Institute (NCI) funded clinical tri...
ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
- Multi-Center Study in Skin Graft Donor Site Patients -
ADDISON, Texas, Oct. 21 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE
Alternext: ULU) today announced that it has commenced a clinical study to
evaluate patients with graft donor sites treated with Altrazeal(TM) Silver
Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology
Patient calls it a 'miracle'
LATHAM, N.Y., Aug. 25 /PRNewswire-FirstCall/ -- Clinicians from the
Image Guided Radiation Therapy program at Community Care Physicians in
Latham have commenced treating cancer patients using
radiotherapy technology from Varian Me...
Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments
8-year-old patient receives 'hidden scar' procedure; Pediatrics becomes 4th
surgical specialty to benefit from single port surgery with RealHand HD instruments
CUPERTINO, Calif., July 28 /PRNewswire/ -- Novare Surgical Systems
announced the successful completion of...
CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
- State-of-the-Art PET Study Confirms Tyrima Exhibits Excellent Drug-Like Properties - - Results Support Initiation of Phase II Clinical Trials -
RESEARCH TRIANGLE PARK, N.C., July 22 /PRNewswire/ -- CeNeRx BioPharma,
Inc., a clinical stage company developing ...
Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms
OAK LAWN, Ill., June 20 /PRNewswire-USNewswire/ -- Advocate Christ
Medical Center in Oak Lawn, Ill. has become one of only a few institutions
in the Chicago area, the only one in the Advocate Health Care system and
among about 25 hospitals nationally that are using
a glue-like liquid for
Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results
MIDLOTHIAN, Va., June 12 /PRNewswire/ -- On Friday, Inspire
Pharmaceuticals (Nasdaq: ISPH ) announced positive top-line results of the
first Phase 3 trial with denufosol tetrasodium inhalation solution
delivered via PARI's LC STAR nebulizer and PRONEB Ultra compressor for the
treatment of cys...
Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin
Results from a 24-week multi-center, randomized, open-label study presented at ADA 2008
SAN FRANCISCO, June 9 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (Nasdaq: AMLN ) today announced data showing that the use of mealtime
SYMLIN(R) (pramlintide acetate)...
Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
SAN DIEGO, May 19 /PRNewswire/ -- DDW 2008 Annual Meeting -- Ethicon
Endo-Surgery announced today that the results from its pivotal trial
demonstrated physician/nurse teams using
the SEDASYS(TM) System reduced the
risk of over sedation with propofol in patients undergoing screening and
Latest Cell Publication Describes the Novel Kinase Regulators Using OriGene's Functional Kinome Collection
ROCKVILLE, Md., May 5th /PRNewswire/ -- Scientists from University of
Helsinki, Institute of Molecular Medicine in Finland and OriGene
Technologies joined effort in creating the most comprehensive kinome
collection of nearly all predicted human protein kinases, including the
RICE MEMORIAL HOSPITAL PHARMACY STAFF EXPERIENCES A 55% REDUCTION IN TIME SPENT MANAGING PATIENT-SPECIFIC MEDICATIONS USING OMNICELL SINGLEPOINTE SOLUTION
Findings of pre- and post study at Rice Memorial Hospital translates into increased efficiency of pharmacist and nursing staff
MOUNTAIN VIEW, Calif. and WILLMAR, Minn., April 17
/PRNewswire-FirstCall/ -- Omnicell, Inc. (Nasdaq: OMCL ) a leading provider
of system solutions targeting p...
Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology
CEDAR KNOLLS, N.J., April 16 /PRNewswire-FirstCall/ -- Emisphere
Technologies, Inc. (Nasdaq: EMIS ) announced today that additional
preclinical in vivo studies using
dogs further demonstrate that its
proprietary eligen(R) technology enhances the absorption of oral B12. These
data confirm in a...
Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
CEDAR KNOLLS, N.J., March 19 /PRNewswire-FirstCall/ -- Emisphere
Technologies, Inc. (Nasdaq: EMIS ) released today results of additional
animal studies demonstrating that its proprietary eligen(R) technology
enhances the absorption of oral B12 at considerably lower doses than were
ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
Greater than 90% Success Rate at Six-Month Follow-up of 57 Patients
MINNEAPOLIS, Feb. 22 /PRNewswire-FirstCall/ -- ATS Medical, Inc.
(Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac
surgery products, today announced initial clinical results of stand-alone
Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
- Dr. Benjamin Ascher, a Leading French Plastic Surgeon, Will Present his
UltraShape Clinical Results at the International Society of Aesthetic Plastic Surgery Meeting in Melbourne, AU From Feb. 10-13
YOQNEAM, Israel and SAN RAMON, Calif., Feb. 10 /PRNewswire/ -- Renowned
Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
CEDAR KNOLLS, N.J., Feb. 7 /PRNewswire-FirstCall/ -- Emisphere
Technologies, Inc. (Nasdaq: EMIS ) announced today that recent animal
studies have demonstrated proof of concept that absorption of oral vitamin
the company's proprietary eligen(R) technology was 15-30 times
Study Reports Successful Cloning of Human Embryo Using Adult DNA
Key Step Toward Developing Embryonic Stem Cell Lines for Therapeutic Cloning
DURHAM, N.C., Jan. 17 /PRNewswire/ -- A California research team has
become the first to report, and painstakingly document, the cloning of a
human embryo using
donated oocytes (egg ce...
Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
MENLO PARK, Calif., Jan. 16 /PRNewswire/ -- Fundamental Applied
Biology, Inc. (FAB) announced today that it has been awarded a Small
Business Innovative Research (SBIR) Phase IIB grant from the National
Science Foundation. The $500,000 grant will be used to continue to develop
FAB's cell-free ...
Universite de Montreal Researchers Simulate World's Largest Heart Model Using SGI Technology
1.2TB SGI Altix Shared Memory System Runs 'Heart Model of the Future' Today, Accelerating Researchers' Time To Insight
SUNNYVALE, Calif., Jan. 15 /PRNewswire-FirstCall/ -- In the quest to
discover how the mechanisms of disease work, researchers at the Universite
de Montreal (UdM) h...
Positive Results Published Using AtriCure Minimally Invasive Products
WEST CHESTER, Ohio, Jan. 7 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC ), a medical device company and a leader in cardiac surgical
ablation products, today announced that results reporting on the Company's
proprietary minimally invasive products, which physicians have adopted to
Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
Bubble CPAP system improves outcomes for premature babies
FORT WORTH, Texas, Dec. 10 /PRNewswire-USNewswire/ -- Bubbles have
entertained kids for generations. Now, they are helping improve the care of
premature infants. Harris Methodist Fort Worth Hospital's (HMFW) neonatal
intensive care ...
Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
NUTLEY, N.J., Oct. 23 /PRNewswire/ -- Today, Roche announced positive
results from a Phase I trial of R1507, a human monoclonal antibody to
target IGF-1R (insulin-like growth factor receptor), in patients with solid
tumors. IGF-1 is one of the most potent natural activators of the AKT and
Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
- Lesions non-invasively imaged in 5 to 10 minutes - - Landmark Study Reported in Journal of Investigative Dermatology -
ROCHESTER, N.Y., Sept. 18 /PRNewswire/ -- A landmark publication that
appeared in the Journal of Investigative Dermatology reports the results of
a large, two sit...
Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
BRANFORD, Conn., Sept. 6 /PRNewswire/ -- 454 Life Sciences, a Roche
company, today announced that researchers at Columbia University, in
collaboration with 454, have identified a virus implicated in the deaths of
2.4 million honeybee colonies -- tens of billions of bees -- using